Structure and function of immunoglobulins

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 2 SUPPL. 2, 2010, Pages

  Schroeder Jr , Harry W ^a   Cavacini, Lisa ^b  

^a The University of Alabama at Birmingham   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

antibody function; Antibody structure; class switching; immunoglobulin function; immunoglobulin gene rearrangement; immunoglobulin structure; somatic hypermutation

Indexed keywords

ANTIGEN; CYTIDINE DEAMINASE; EPITOPE; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN IDIOTYPE; IMMUNOGLOBULIN M;

ADD ON THERAPY; ALLERGY; ANTIBODY COMBINING SITE; ANTIBODY STRUCTURE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; BINDING AFFINITY; COMPLEMENTARITY DETERMINING REGION; GENE LOCUS; GENE REARRANGEMENT; GENE SEQUENCE; GLYCOSYLATION; HEAVY CHAIN; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; SOMATIC HYPERMUTATION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; GENE REARRANGEMENT, B-LYMPHOCYTE; GLYCOSYLATION; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNITY, INNATE; IMMUNOGLOBULINS; ORGAN SPECIFICITY; PROTEIN MULTIMERIZATION; RECEPTORS, FC; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 76749113309     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.09.046     Document Type: Article

References (52)

1. Williams A.F., and Barclay A.N. The immunoglobulin superfamily-domains for cell surface recognition. Annu Rev Immunol 6 (1988) 381-405
2. Harpaz Y., and Chothia C. Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. J Mol Biol 238 (1994) 528-539
3. Torres R.M., Imboden J., and Schroeder Jr. H.W. Antigen receptor genes, gene products, and co-receptors. In: Rich R.R., Fleisher T.A., Shearer W.T., Schroeder Jr. H.W., Frew A.J., and Weyand C.M. (Eds). Clinical immunology: principles and practice. 3rd ed (2008), Mosby Elsevier, London 53-77
4. Smith K.A., Nelson P.N., Warren P., Astley S.J., Murray P.G., and Greenman J. Demystified...recombinant antibodies. J Clin Pathol 57 (2004) 912-917
5. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., et al. Naturally occurring antibodies devoid of light chains. Nature 363 (1993) 446-448
6. Roux K.H., Greenberg A.S., Greene L., Strelets L., Avila D., McKinney E.C., et al. Structural analysis of the nurse shark (new) antigen receptor (NAR): molecular convergence of NAR and unusual mammalian immunoglobulins. Proc Natl Acad Sci U S A 95 (1998) 11804-11809
7. Vincke C., Loris R., Saerens D., Martinez-Rodriguez S., Muyldermans S., and Conrath K. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J Biol Chem 284 (2009) 3273-3284
8. Jazwinska E.C., Dunckley H., Propert D.N., Gatenby P.A., and Serjeantson S.W. GM typing by immunoglobulin heavy chain gene RFLP analysis. Am J Hum Genet 43 (1988) 175-181
9. Leder P. The genetics of antibody diversity. Sci Am 246 (1982) 102-115
10. Tonegawa S. Somatic generation of antibody diversity. Nature 302 (1983) 575-581
11. Dudley D.D., Chaudhuri J., Bassing C.H., and Alt F.W. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences. Adv Immunol 86 (2005) 43-112
12. Zachau H.G. The human immunoglobulin kappa genes. In: Honjo T., Alt F.W., and Rabbitts P.H. (Eds). Immunoglobulin genes. 2nd ed (1995), Academic Press, London 173
13. Brodeur P.H., and Riblet R.J. The immunoglobulin heavy chain variable region (IgH-V) locus in the mouse. I. One hundred Igh-V genes comprise seven families of homologous genes. Eur J Immunol 14 (1984) 922-930
14. Kirkham P.M., and Schroeder Jr. H.W. Antibody structure and the evolution of immunoglobulin V gene segments. Semin Immunol 6 (1994) 347-360
15. Lee S.K., Bridges Jr. S.L., Koopman W.J., and Schroeder Jr. H.W. The immunoglobulin kappa light chain repertoire expressed in the synovium of a patient with rheumatoid arthritis. Arthritis Rheum 35 (1992) 905-913
16. Kawasaki K., Minoshima S., Nakato E., Shibuya K., Shintani A., Schmeits J.L., et al. One-megabase sequence analysis of the human immunoglobulin lambda gene locus. PCR Methods Appl 7 (1997) 250-261
17. Bankovich A.J., Raunser S., Juo Z.S., Walz T., Davis M.M., and Garcia K.C. Structural insight into pre-B cell receptor function. Science 316 (2007) 291-294
18. Matsuda F., Ishii K., Bourvagnet P., Kuma K., Hayashida H., Miyata T., et al. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med 188 (1998) 2151-2162
19. Corbett S.J., Tomlinson I.M., Sonnhammer E.L., Buck D., and Winter G. Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol 270 (1997) 587-597
20. Honjo T. Immunoglobulin genes. Annu Rev Immunol 1 (1983) 499-528
21. Dorner T., Foster S.J., Farner N.L., and Lipsky P.E. Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands. Eur J Immunol 28 (1998) 3384-3396
22. Rada C., Ehrenstein M.R., Neuberger M.S., and Milstein C. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 9 (1998) 135-141
23. Neuberger M.S. Antibody diversification by somatic mutation: from Burnet onwards. Immunol Cell Biol 86 (2008) 124-132
24. Muramatsu M., Nagaoka H., Shinkura R., Begum N.A., and Honjo T. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol 94 (2007) 1-36
25. Matthias P., and Rolink A.G. Transcriptional networks in developing and mature B cells. Nat Rev Immunol 5 (2005) 497-508
26. Normansell D.E. Human immunoglobulin subclasses. Diagn Clin Immunol 5 (1987) 115-128
27. Torres M., and Casadevall A. The immunoglobulin constant region contributes to affinity and specificity. Trends Immunol 29 (2008) 91-97
28. Arnold J.N., Wormald M.R., Sim R.B., Rudd P.M., and Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 25 (2007) 21-50
29. Liu H., Bulseco G.-G., and Sun J. Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody. Immunol Lett 106 (2006) 144-153
30. Siberil S., de Romeuf C., Bihoreau N., Fernandez N., Meterreau J.L., Regenman A., et al. Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions. Clin Immunol 118 (2006) 170-179
31. Sazinsky S.L., Ott R.G., Silver N.W., Tidor B., Ravetch J.V., and Wittrup K.D. Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors. Proc Natl Acad Sci U S A 105 (2008) 20167-20172
32. Kanda Y., Yamada T., Mori K., Okazaki A., Inoue M., Kitajima-Miyama K., et al. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high mannose, hybrid and complex types. Glycobiology 17 (2006) 104-118
33. Natsume A., Wakitani M., Yamane-Ohnuki N., Shoji-Hosaka E., Niwa R., Uchida K., et al. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region. J Immunol Methods 306 (2005) 93-103
34. Arnold J.N., Dwek R.A., Rudd P.M., and Sim R.B. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett 106 (2006) 103-110
35. Albert H., Collin M., Dudziak D., Ravetch J.V., and Nimmerjahn F. In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc Natl Acad Sci U S A 105 (2009) 15005-15009
36. Anthony R.M., Wermeling F., Karlsson M.C., and Ravetch J.V. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci U S A 105 (2008) 19571-19578
37. Miranda L.R., Duval M., Doherty H., Seaman M.S., Posner M.R., and Cavacini L.A. The neutralization properties of a HIV-specific antibody are markedly altered by glycosylation events outside the antigen-binding domain. J Immunol 178 (2007) 7132-7138
38. Collin M., Shannon O., and Bjorck L. IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc Natl Acad Sci U S A 105 (2008) 4265-4270
39. Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37 (2000) 1141-1149
40. Riesbeck K., and Nordstrom T. Structure and immunological action of the human pathogen Moraxella catarrhalis IgD-binding protein. Crit Rev Immunol 26 (2006) 353-376
41. Geisberger R., Lamers M., and Achatz G. The riddle of the dual expression of IgM and IgD. Immunology 118 (2006) 429-437
42. Parlowsky T., Welzel J., Amagai M., Zillikens D., and Wygold T. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns. J Am Acad Dermatol 48 (2003) 623-625
43. Yeh S.W., Cavacini L.A., Bhol K.C., Lin M.S., Kumar M., Duval M., et al. Pathogenic human monoclonal antibody against desmoglein 3. J Immunol 120 (2006) 68-75
44. Cavacini L.A., Kuhrt D., Duval M., Mayer K., and Posner M. Binding and neutralization activity of IgG1 and IgG3 from serum of HIV infected individuals. AIDS Res Hum Retroviruses 19 (2003) 785-792
45. Scharf O., Golding H., King L.R., Eller N., Frazier D., Golding B., et al. Immunoglobin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1. J Virol 75 (2001) 6558-6565
46. Woof J.M., and Mestecky J. Mucosal immunoglobulins. Immunol Rev 206 (2005) 64-82
47. Stubbe H., Berdoz J., Kraehenbuhl J.P., and Corthesy B. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J Immunol 164 (2000) 1952-1960
48. Corthesy B. Roundtrip ticket for secretory IgA: role in mucosal homeostasis?. J Immunol 178 (2007) 27-32
49. Chang T.W., Wu P.C., Hsu C.L., and Hung A.F. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases. Adv Immunol 93 (2007) 63-119
50. Nimmerjahn F., and Ravetch J.V. FC-receptors are regulators of immunity. Adv Immunol 96 (2007) 179-204
51. Hinton P.R., Johlfs M.G., Xiong J.M., Hanestad K., Ong K.C., Bullock C., et al. Engineered human IgG antibodies with longer serum half-lives in primates. J Biol Chem 279 (2004) 6213-6216
52. Petkova S.B., Akilesh S., Sproule T.J., Christianson G.J., Al Khabbaz H., Brown A.C., et al. Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int Immunol 18 (2006) 1759-1769